The subpopulation of breast cancer cells with high level of stem cell markers (CD44, ALDH1, CD133, OCT4, SOX2 and Nanog) exhibit the capacities of self-renewal and multi-directional differentiation, playing critical roles in tumor initiation, therapeutic resistance, relapse, and metastasis [7–9]. This evidence concerns the gene CD44 and breast cancer.